N-tert-butyl-2-[1-[(4-chlorophenyl)methyl]-2-(3,5-dimethylphenyl)indol-5-yl]-2-methylpropanamide
C31H35ClN2O — CID 25101374
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-tert-butyl-2-[1-[(4-chlorophenyl)methyl]-2-(3,5-dimethylphenyl)indol-5-yl]-2-methylpropanamide
N-tert-butyl-2-[1-[(4-chlorophenyl)methyl]-2-(3,5-dimethylphenyl)indol-5-yl]-2-methylpropanamide (PubChem CID 25101374) has the molecular formula C31H35ClN2O and a molecular weight of 487.09 g/mol. Its IUPAC name is N-tert-butyl-2-[1-[(4-chlorophenyl)methyl]-2-(3,5-dimethylphenyl)indol-5-yl]-2-methylpropanamide.
Molecular Properties
| Compound Name | N-tert-butyl-2-[1-[(4-chlorophenyl)methyl]-2-(3,5-dimethylphenyl)indol-5-yl]-2-methylpropanamide |
|---|---|
| PubChem CID | 25101374 |
| Molecular Formula | C31H35ClN2O |
| Molecular Weight | 487.09 g/mol |
| Exact Mass | 486.24 |
| IUPAC Name | N-tert-butyl-2-[1-[(4-chlorophenyl)methyl]-2-(3,5-dimethylphenyl)indol-5-yl]-2-methylpropanamide |
| SMILES | Cc1cc(C)cc(-c2cc3cc(C(C)(C)C(=O)NC(C)(C)C)ccc3n2Cc2ccc(Cl)cc2)c1 |
| InChI | InChI=1S/C31H35ClN2O/c1-20-14-21(2)16-23(15-20)28-18-24-17-25(31(6,7)29(35)33-30(3,4)5)10-13-27(24)34(28)19-22-8-11-26(32)12-9-22/h8-18H,19H2,1-7H3,(H,33,35) |
| InChIKey | RXCDVLIVKHGFTH-UHFFFAOYSA-N |
| XLogP | 7.82 |
| TPSA | 34.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 487.09 |
| LogP ≤ 5 | 7.82 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25101374 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.